HVC

Healthcare Value Capital Portfolio holdings

AUM $38.5M
This Quarter Return
+0.14%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
AUM
$42.1M
AUM Growth
+$42.1M
Cap. Flow
+$8.07M
Cap. Flow %
19.14%
Top 10 Hldgs %
100%
Holding
15
New
2
Increased
2
Reduced
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TYME
1
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$11M 21.92% +2,075,000 New +$11M
PFE icon
2
Pfizer
PFE
$141B
$8.93M 17.86% 250,000
NVLN
3
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$6.2M 12.4% 881,440 +50,000 +6% +$352K
GILD icon
4
Gilead Sciences
GILD
$140B
$6.08M 12.16% 75,000
ASRT icon
5
Assertio
ASRT
$80.4M
$4.05M 8.11% 700,000 +150,000 +27% +$869K
GSK icon
6
GSK
GSK
$79.9B
$2.03M 4.06% +50,000 New +$2.03M
LAB icon
7
Standard BioTools
LAB
$481M
$1.82M 3.64% 360,500
AMRN
8
Amarin Corp
AMRN
$311M
$1.58M 3.15% 450,000
BIS icon
9
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
$514K 1.03% 25,000
AORT icon
10
Artivion
AORT
$2.07B
0
TEVA icon
11
Teva Pharmaceuticals
TEVA
$21.1B
-75,000 Closed -$2.49M
VIXY icon
12
ProShares VIX Short-Term Futures ETF
VIXY
$87.1M
0
IMMU
13
DELISTED
Immunomedics Inc
IMMU
0
AGN
14
DELISTED
Allergan plc
AGN
-15,000 Closed -$3.65M
FCSC
15
DELISTED
Fibrocell Science Inc.
FCSC
0